PubMed دسترسی آزاد

The gut microbiome and mitochondrial function in metabolism, immunity, and disease.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

The gut microbiome is a key regulator of host physiology, yet its effects remain difficult to predict across individuals and contexts. Similar microbial compositions frequently give rise to divergent and delayed phenotypic outcomes, indicating that models based solely on signal strength or steady-state responses are insufficient to explain microbiome-driven host function. In this review, we propose a conceptual perspective in which microbiome-associated variability is shaped by the capacity of host cells to maintain mitochondrial function under persistent metabolic and immune stress. Microbiome-derived metabolites and immune activity define the metabolic and redox environments that constrain mitochondrial performance, thereby influencing how effectively cells recover from repeated stress. When mitochondrial membrane potential, redox balance, and energy production are not fully restored, mitochondria may show increased engagement of quality-control pathways. Over repeated stress-recovery cycles, this pattern may be associated with reduced functional reserve despite preserved baseline activity. This testable perspective may help explain why microbiome-associated phenotypes are delayed, variable, and context-dependent, and it highlights mitochondrial recovery capacity as a potential determinant of disease vulnerability and host-microbiome interactions.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Gut microbiomecellular stress responsehost–microbe interactionsimmunometabolismmitochondrial function
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Day-to-day variability in resting metabolic rate in strength athletes.

BACKGROUND: Resting Metabolic Rate (RMR) is measured in sport settings for health monitoring and nutrition planning; however, interpreting repeated measures requires an understanding of typical day-to-day variability under habitual, free-living conditions. This study quantified intra-individual variability in RMR among weight-stable strength-trained athletes, examined the impact of data processing approaches, and established protocol-s…

PubMed2026

Investigating and validating the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development based on single-cell, bulk transcriptomics, and RT-qPCR.

Myasthenia gravis (MG) is a complex autoimmune neuromuscular disorder, and the role of lipid metabolism dysregulation in MG pathogenesis remains unclear. This study aimed to investigate the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development by integrating single-cell and bulk transcriptomic data. This study analyzed bulk RNA sequencing data from the GSE85452 dataset (13 MG patients and 12 healthy contr…

PubMed2026

Lactobacillus johnsonii mediates the protective effects of pristimerin against ulcerative colitis and concomitant liver injury through remodeling hepatic lipid metabolism via LXRα-SCD1 axis.

Ulcerative colitis (UC) is a systemic disease that can involve multiple organs, and hepatobiliary diseases in UC patients are frequently observed. However, the pathogenesis of UC and its associated hepatobiliary complications remains elusive, and limited therapeutic options are available. This study revealed that disrupted hepatic lipid metabolism plays a pivotal role in driving the progression of UC and its extraintestinal hepatobilia…

PubMed2026

A NANOBODY molecule that blocks MerTK ectodomain cleavage in vitro and in vivo.

The membrane receptor MerTK is critical for the resolution of inflammation and thus is of pharmacological interest. MerTK function is inhibited by the proteolytic cleavage of its extracellular domain leading to the formation of soluble Mer (sMer). We describe here the NANOBODY molecule A0445046C08 and its half-life-extended version A044500050. Both bound selectively to MerTK and blocked lipopolysaccharide-induced MerTK cleavage in prim…